Cloud services provider, Amazon Web Services (AWS), in collaboration with the American Heart Association (AHA) has launched a global, secure cloud-based data marketplace that will provide researchers and clinicians with diverse data to accelerate solutions for cardiovascular diseases.

The AHA Precision Medicine Platform will be managed on the AWS cloud and will include a vast array of curated rich datasets that are centrally stored, easily searched and accessible.

According to AHA, the platform will enable researchers and clinicians to aggregate and analyse data that includes longitudinal cohorts, proteomic, genomic and gene expression data, using a precision medicine approach to uncover critical cardiovascular disease insights that translate into medical innovations that positively impact millions of lives.

Precision cardiovascular medicine takes into account an individual’s biology, environment and lifestyle and is driven by advanced methods of aggregating, integrating and analysing patient data to develop prevention and treatment strategies for individuals.

The platform will integrate de-identified data from clinical trials, long-running epidemiologic studies, clinical registries and real-time health data acquired through wearable devices and technology.

“The platform will harness the power of big data to revolutionise the way cardiovascular research is performed and speed the promise of precision cardiovascular medicine,” said AHA CEO, Nancy Brown.

“The AHA remains steadfast in its commitment to eliminate the tragic global burden cardiovascular disease places on individuals, families, healthcare systems and entire nations by mapping scientific discovery to the dramatic advances in biomedical research and technology innovation,” continued Brown.

“AHA and AWS bring unique strengths and complementary expertise to the Precision Medicine Data Marketplace with AWS offering the immense computational and analytical power necessary to manage the information ecosystem of this magnitude,” said Vice President Worldwide Public Sector, AWS, Inc., Teresa Carlson.

“We are very excited to work with AHA to quickly bring resources and advancements to patients more rapidly and to make these scientific discoveries a reality,” continued Carlson.

Several initial healthcare and research organisations are leading the way as data contributors to the AHA Precision Medicine Platform. These include AstraZeneca; Cedars Sinai Heart Institute; Dallas Heart Study; the Duke Clinical Research Institute (DCRI); Intermountain Medical Center Heart Institute; the International Stroke Genetics Consortium; and Stanford Cardiovascular Institute.

To spark collaboration, AHA is providing access to the Precision Medicine Platform through a series of grants. AWS is providing grant recipients free access to computational cloud storage and analysis as part of the AHA data grant portfolio. Grant submissions are in progress and the first round of recipients will be announced in April 2017.

The Precision Medicine Platform will be available at and is a marquee project of the AHA Institute for Precision Cardiovascular Medicine.

For more information contact, like us on Facebook or tweet us @eHealthNewsZA.